News
![NICE1](https://pharmaphorum.com/wp-content/uploads/2016/10/NICE1.jpg)
NICE backs Biogen's Vumerity for multiple sclerosis
Patients with relapsing-remitting multiple sclerosis (RRMS) in England, Wales and Northern Ireland can now access treatment with Biogen's oral therapy Vumerity, after NICE recommended the d